We are a Bio Pharma leader focused on helping to address the
unmet medical needs of patients with serious diseases.
In 2013, we invested $3.7 billion in the discovery and development of
medicines, including key areas such as oncology, virology, immunology,
cardiovascular and diabetes.
Here is a list of our company's marketed products.
Disclaimer: Please consult your physician for professional medical
advice and services.